Astellas Pharma Inc Unsponsored ADR (Japan) share price logo

Astellas Pharma Inc Unsponsored ADR (Japan)

OTC: ALPMY

Large Cap

$15.93

+0.16

(+0.98%)

Live

as on

Astellas Pharma Inc Unsponsored ADR (Japan) Stock Performance

as on October 24, 2026 at 6:18 am IST

  • Day's Low

    Day's High

    $15.61
    $15.99
    downward going graph

    2.01%

    Downside

    0.38%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Astellas Pharma Inc Unsponsored ADR (Japan) share price movements today

Previous Close
$15.77
Open
$15.67
Volume
221.4K
Market Cap
$28.1B
Dividend Yield
0.03%
Day's Low - High
$15.61 - $15.99

Astellas Pharma Inc Unsponsored ADR (Japan) Historical Returns

1 Month Return
+ 4.71 %
3 Month Return
+ 20.47 %
1 Year Return
+ 47.25 %
3 Year Return
+ 21.49 %
5 Year Return
0 %

Astellas Pharma Inc Unsponsored ADR (Japan) Stock Fundamentals & Key Indicators

Check Astellas Pharma Inc Unsponsored ADR (Japan) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.1B

EPS (TTM)

0.9535

Dividend Yield

0.03%

PE Ratio (TTM)

11.88

Industry PE ratio

9.58

PEG Ratio

0.00

Return On Equity TTM

21.30%

Astellas Pharma Inc Unsponsored ADR (Japan) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Astellas Pharma Inc Unsponsored ADR (Japan) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$28.1BNA11.8816.05%0.03%
StrongBuy$1.2T436.08%42.5183.40%0.53%
StrongBuy$510.8B161.31%80.2171.48%2.43%
Buy$621.2B63.46%39.0868.81%2.05%
Buy$365.9B81.44%118.9875.38%2.27%

Stock Returns calculator for Astellas Pharma Inc Unsponsored ADR (Japan) Stock including INR - Dollar returns

The Astellas Pharma Inc Unsponsored ADR (Japan) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Astellas Pharma Inc Unsponsored ADR (Japan) investment value today

Current value as on today

₹1,60,874

Returns

₹60,874

(+60.87%)

Returns from Astellas Pharma Inc Unsponsored ADR (Japan) Stock

₹48,739 (+48.74%)

Dollar Impact

₹12,134 (+12.13%)

Indian Investors' Interest in Astellas Pharma Inc Unsponsored ADR (Japan) Stock

Search interest for Astellas Pharma Inc Unsponsored ADR (Japan) Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Astellas Pharma Inc Unsponsored ADR (Japan) Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2,767
473,124
462,497
517,408
459,294
505,794
533,461
581,517
647,485
649,353
Gross Profit
2,060
381,988
379,808
418,885
382,436
410,965
392,799
429,696
457,557
488,892
Operating Income
37,724
30,544
63,166
-116,191
63,520
94,647
109,517
126,954
113,890
188,187
EBITDA
4,168
-67,847
88,050
126,058
101,785
151,845
156,854
188,935
-52,625
238,732
Interest Expense
4,186
324
4,507
2,167
2,967
4,231
2,740
2,490
5,459
3,162
Depreciation
48,643
-
-
-
-
-
-
-
-
-
Income Before Tax
-48,662
50,495
38,547
-118,359
60,554
90,416
106,007
136,375
66,499
188,970
Income Tax Expense
-15,384
12,892
2,639
-20,699
-14,342
21,994
25,412
34,241
8,492
45,351
Net Income
-222
37,603
35,908
-97,660
74,896
68,422
80,594
102,134
57,966
143,541
Net Profit Margin
-8.03%
7.95%
7.76%
-18.87%
16.31%
13.53%
15.11%
17.56%
8.95%
22.11%

Astellas Pharma Inc Unsponsored ADR (Japan) Annual Profit & Loss

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Revenue
11,616
12,259
11,752
12,103
11,497
10,953
11,362
10,705
12,824
2,268,258
Gross Profit
8,460
9,147
8,807
9,331
9,014
8,576
8,917
8,752
10,483
1,691,018
Operating Income
276,419
271,241
280,141
279,419
136,051
155,686
285,430
25,518
41,039
445,009
EBITDA
347,536
284,758
313,727
314,750
220,311
241,519
246,878
194,814
248,046
639,603
Interest Expense
1,334
1,309
1,302
3,004
2,335
4,949
8,779
12,005
17,677
14,920
Depreciation
-
64,863
63,458
66,396
72,652
79,684
105,738
157,840
199,132
194,594
Income Before Tax
281,769
218,113
248,967
247,010
144,846
156,397
132,361
24,969
31,237
399,298
Income Tax Expense
63,069
53,434
26,702
49,939
24,734
32,800
33,647
7,924
-19,510
90,139
Net Income
1,936
1,552
1,999
1,818
1,109
1,048
738
113
340
309,116
Net Profit Margin
16.67%
12.66%
17.01%
15.02%
9.65%
9.57%
6.50%
1.06%
2.65%
13.63%

Astellas Pharma Inc Unsponsored ADR (Japan) Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
37,603
35,908
-97,660
74,896
68,422
80,594
102,134
57,966
143,541
Operating Cash Flow
12,600
64,811
16,026
101,075
386
237,058
75,107
207,503
88,781
Investing Cash Flow
-39,349
-16,383
-30,722
-2,965
-122
-15,623
-17,845
-22,440
-71,321
Financing Cash Flow
-11,919
-54,340
-104,296
-90,812
-76
-149,625
-93,566
-160,787
-53,645
Change in Cash
302,928
-302,928
179,865
8,507
215,399
67,890
-50,402
23,606
-42,703

Astellas Pharma Inc Unsponsored ADR (Japan) Annual Cash Flow

All numbers in Millions USD

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Income
164,679
222,265
245,350
145,324
156,886
132,361
17,045
31,237
309,116
Operating Cash Flow
314,463
261,428
221,998
306,843
257,444
327,767
172,475
194,512
600,400
Investing Cash Flow
-123,648
-44,555
-389,793
-81,894
-62,413
-89,058
-845,802
-89,419
-77,174
Financing Cash Flow
-203,429
-233,681
181,055
-229,479
-216,298
-195,623
614,060
-261,367
-429,190
Change in Cash
-9,192
-20,657
7,317
7,737
-10,142
60,854
-41,153
-147,315
81,555

Global Institutional Holdings in Astellas Pharma Inc Unsponsored ADR (Japan)

Check out the Institutions with significant holdings in Astellas Pharma Inc Unsponsored ADR (Japan).

Funds
Holdings
iShares
0.03%
ActivePassive
0.00%
SP Funds
0.00%
Abacus
0.00%
Avantis
0.00%

Astellas Pharma Inc Unsponsored ADR (Japan) News & Key Events

    Insights on Astellas Pharma Inc Unsponsored ADR (Japan)

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 3 months, ALPMY stock has moved up by 20.5%

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 6 quarters, 459.29B → 649.35B (in $), with an average increase of 6.6% per quarter

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, 57.96B → 143.54B (in $), with an average increase of 59.6% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Merck & Co., Inc. has given 68.9% return, outperforming this stock by 21.7%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Eli Lilly & Co. has given 42.5% return, outperforming this stock by 21.0%

    About Astellas Pharma Inc Unsponsored ADR (Japan)

    Astellas Pharma Inc. engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally. The company offers XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for acute myeloid leukemia; VYLOY, a treatment for gastric adenocarcinoma and esophagogastric junction adenocarcinoma; and PADCEV, a treatment for patients with metastatic urothelial carcinoma. It also provides VEOZAH, a treatment for vasomotor symptoms associated with menopause; IZERVAY, a treatment for age-related macular degeneration with geographic atrophy; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf, an immunosuppressant. It offers its products to oncology, ophthalmology, urology, immunology, and women's health areas. The company was formerly known as Yamanouchi Pharmaceutical Co. Ltd. and changed its name to Astellas Pharma Inc. in April 2005. Astellas Pharma Inc. was founded in 1923 and is headquartered in Chuo, Japan.
    OrganisationAstellas Pharma Inc Unsponsored ADR (Japan)
    Headquarters2-5-1, Nihonbashi-Honcho, Chuo, Japan, 103-8411
    IndustryDrug Manufacturers - General
    CEOMr. Naoki Okamura BSc

    Key Management of Astellas Pharma Inc Unsponsored ADR (Japan)

    Name

    Title

    Ms. Leticia Delgado-Herrera

    VP and Rx+ M&D Head

    Mr. Katsuyoshi Sugita

    Executive VP, Chief People Officer & Representative Director

    Mr. Atsushi Kitamura

    Chief Financial Officer

    Mr. Yoshitsugu Shitaka Ph.D.

    Chief Scientific Officer & Senior Managing Executive Officer

    Ms. Nobuko Kato

    Chief Communications & Investor Relations Officer

    Mr. Jun Kono M.B.A.

    Senior Executive Officer & Head of Japan Commercial

    Mr. Naoki Okamura BSc

    President, CEO & Representative Director

    Nobue Yasuda

    General Manager of Finance & Accounting Department

    Ms. Nahrin Marino

    General Counsel and Chief Ethics & Compliance Officer

    Mr. Nobuaki Tanaka

    President of Japan Commercial & Senior Corporate Executive

    FAQs

    What is Astellas Pharma Inc Unsponsored ADR (Japan) share price today?

    Astellas Pharma Inc Unsponsored ADR (Japan) share price today is $15.93 as on . Astellas Pharma Inc Unsponsored ADR (Japan) share today touched a day high of $15.99 and a low of $15.61.

    What is the 52 week high and 52 week low for Astellas Pharma Inc Unsponsored ADR (Japan) share?

    Astellas Pharma Inc Unsponsored ADR (Japan) share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Astellas Pharma Inc Unsponsored ADR (Japan) stock price today i.e. is trending at $15.93,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

    What is Astellas Pharma Inc Unsponsored ADR (Japan)'s market capitalisation today?

    Astellas Pharma Inc Unsponsored ADR (Japan) market capitalisation is $0.03T as on .

    How to invest in Astellas Pharma Inc Unsponsored ADR (Japan) Stock (ALPMY) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Astellas Pharma Inc Unsponsored ADR (Japan) on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Astellas Pharma Inc Unsponsored ADR (Japan) Stock (ALPMY) from India?

    Indian investors can start investing in Astellas Pharma Inc Unsponsored ADR (Japan) (ALPMY) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.40 in Astellas Pharma Inc Unsponsored ADR (Japan) stock (as per the Rupee-Dollar exchange rate as on ). Based on Astellas Pharma Inc Unsponsored ADR (Japan) share’s latest price of $15.93 as on October 24, 2026 at 12:48 am IST, you will get 0.6277 shares of Astellas Pharma Inc Unsponsored ADR (Japan). Learn more about fractional shares .